iNtRON Biotechnology has announced that its New Drug Part has entered into an official contract with the U.S. Army DEVCOM (U.S. Army Combat Capabilities Development Command) International Technology Center Indo-Pacific and Solider Center to develop bacteriophages for combating Uropathogenic Escherichia coli (UPEC) infections.